Concepedia

Xiaolan Bian

XB

19

Publications

426

Citations

12

H-Index

2020

Active since

Affiliations

Ruijin Hospital(Current)

Shanghai Jiao Tong University

Shanghai Chest Hospital

Shanghai University of Traditional Chinese Medicine

Fudan University

Xiaolan Bian is an author at Ruijin Hospital specializing in drug discovery, medicine, and toxicology.

ORCID

Top concepts

Publications per year

2020–2024

19

Publications

19

Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling

Size Li, Yiqun Yu, Xiaolan Bian et al. · Archives of Toxicology · 2021 · 64 citations

, , +12

Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study

Guanhao Zheng, Jianxin Zhang, Bei Wang et al. · Infectious Diseases and Therapy · 2021 · 44 citations · Full text

LncRNA TDRG1-Mediated Overexpression of VEGF Aggravated Retinal Microvascular Endothelial Cell Dysfunction in Diabetic Retinopathy

Qiaoyun Gong, Wenpei Dong, Ying Fan et al. · Frontiers in Pharmacology · 2020 · 43 citations · Full text

Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study

Jie Fang, Hui Li, Min Zhang et al. · Frontiers in Pharmacology · 2021 · 35 citations · Full text

Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study

Guanhao Zheng, Jiaqi Cai, Liang Zhang et al. · Infectious Diseases and Therapy · 2022 · 30 citations · Full text

Rows per page

1–5 of 19